Method of Producing Insulin-Producing Cells
OwnerAssam El-Osta, Keith Al-Hasani +5inventors
InventorsAssam El-Osta, Keith Al-Hasani, Ishant Khurana, Harikrishnan Kaipananickal, Scott Stuart Maxwell, Jun Okabe, Safiya Naina Marikar
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods and uses for producing an insulin-producing cell from a pancreatic exocrine cell comprising contacting the pancreatic exocrine cell with an inhibitor of EZH2. The present invention also relates to methods and uses for preventing or treating a disease involving dysfunctional insulin production.
Claims52
A method of producing an insulin-producing cell from a pancreatic exocrine cell, the method comprising:
- contacting a pancreatic exocrine cell, or a cell population comprising a pancreatic exocrine cell, with an inhibitor of EZH2 for a sufficient time and under conditions to allow generation of an insulin-producing cell from the pancreatic exocrine cell,
- thereby producing an insulin-producing cell, or a cell population comprising an insulin-producing cell.
Use of an inhibitor of EZH2 in the manufacture of a composition for producing an insulin-producing cell from a pancreatic exocrine cell.
An inhibitor of EZH2 for use in producing an insulin-producing cell from a pancreatic exocrine cell.
A method for preventing or treating a disease involving dysfunctional insulin production, the method comprising:
- administering an inhibitor of EZH2 to an individual in need thereof such that the inhibitor of EZH2 contacts a pancreatic exocrine cell of the individual for a sufficient time and under conditions to allow generation of an insulin-producing cell from the pancreatic exocrine cell,
- thereby preventing or treating the disease in the individual.
Use of an inhibitor of EZH2 in the manufacture of a composition for preventing or treating a disease involving dysfunctional insulin production in an individual, wherein the inhibitor of EZH2 contacts a pancreatic exocrine cell of the individual for a sufficient time and under conditions to allow generation of an insulin-producing cell from the pancreatic exocrine cell.
An inhibitor of EZH2 for use in preventing or treating a disease involving dysfunctional insulin production in an individual, wherein the inhibitor of EZH2 contacts a pancreatic exocrine cell of the individual for a sufficient time and under conditions to allow generation of an insulin-producing cell from the pancreatic exocrine cell.
Dependencies are inferred from the claim text.